In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 1994 for your search:
Keywords/Phrases:  "traditional Chinese medicine"
Trial Status:  Active
Start Over
        Show
1.

Phase: No phase specified
Type: Treatment
Status: Approved-not yet active
Age: 65 to 80
Sponsor: Other
Protocol IDs: 12401905700zzy, NCT01780181

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: TCM-mCRC, LHYY-11495801300, NCT01975454

3.

Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: CCMP98 -CT-203, NCT01580358

4.

Phase: Phase II
Type: Supportive care
Status: Active
Age: 20 to 80
Sponsor: Other
Protocol IDs: 100610, Protocol Record 100610, NCT01503346

5.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: TPE-1-breast Ca, NCT01142479

6.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: FAHG20070218, NCT01054482

7.

Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: FAHG20100320, NCT01104233

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: FAH20120906, FAHGuangzhou011, NCT01872403

9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: FAHG20081202, NCT00862004

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: FAHG20060216, NCT01051362

11.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: FAHG20100201, NCT01105182

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: FAHG20090601A, NCT00923637

13.

Phase: No phase specified
Type: Educational/Counseling/Training
Status: Active
Age: 50 to 75
Sponsor: Other
Protocol IDs: 1R01CA138778-01A1, NCT00947206

14.

Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: KCC(QEH)/HKBU/NSCLC2012, NCT01681485

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: DMR99-IRB-259, CCMP99-RD-050, NCT01359501

16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: FAHG20120926A, FAHGuangzhou012, NCT01872416

17.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ML25241, NCT01126138

18.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: LPS-GC-01-2008, NCT00639522

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AZA-MDS-002, NCT01599325

20.

Phase: Phase I
Type: Treatment
Status: Active
Age: 76 and over
Sponsor: Other
Protocol IDs: CH-GI-024, NCT01584544

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: LP-101, NCT01832298

22.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: ALTN-02-II, NCT01878448

23.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: ALTN-06-IIA, NCT02072031

24.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: ALTN-06-IIB, NCT02072044

25.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2006 BAI02A02[1]-01, NCT00576914
1     
New Search